Checkpoint Inhibition in Head and Neck Cancer: Immune Therapeutic Options, Limitations, and Beyond

Publisher： Karger

E-ISSN： 1423-0275|79|1-2|24-33

ISSN： 0301-1569

Source： ORL, Vol.79, Iss.1-2, 2017-02, pp. : 24-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Progress in Head and Neck Cancer Immunotherapy: Can Tolerance and Immune Suppression Be Reversed?

By  

ORL, Vol. 66, Iss. 6, 2005-01 ,pp. : 332-340

Karger

Access to resources Recommend Favorite

Radiomics in Head and Neck Cancer: Extracting Valuable Information from Data beyond Recognition

By  

ORL, Vol. 79, Iss. 1-2, 2017-02 ,pp. : 65-71

Karger

Access to resources Recommend Favorite

Quality of Life in Head and Neck Cancer

By Ferlito Alfio   Rogers Simon N.   Shaha Ashok R.   Bradley Patrick J.   Rinaldo Alessandra  

Acta Oto-Laryngologica, Vol. 123, Iss. 1, 2003-01 ,pp. : 8-13

Informa Healthcare

Access to resources Recommend Favorite

Electroporation Therapy in Head and Neck Cancer

By Burian Martin   Formanek Michael   Regele Heinz  

Acta Oto-Laryngologica, Vol. 123, Iss. 2, 2003-01 ,pp. : 264-268

Informa Healthcare

Access to resources Recommend Favorite

Outcomes Research in Head and Neck Cancer

By  

ORL, Vol. 66, Iss. 4, 2004-10 ,pp. : 207-213

Karger

Access to resources Recommend Favorite